Popular Articles

A Compound Found In The Sea Provides Promising New Treatment For Neuropathic Pain
A paper just published in the British Journal of Pharmacology reports that a compound originally isolated from a soft coral (Capnella imbricate) could lead scientists to develop a new variety of treatments for neuropathic pain. This composite is collected at Green Island off Taiwan and could be a new option for treatment. Neuropathic pain is chronic and occasionally follows damage to the nervous system. Presently this type of pain is very poorly controlled by the usual analgesics: aspirin like drugs (NSAIDS) or even opioids like morphine. New treatments are urgently required.
generic viagra online
American Red Cross And ArcelorMittal Launch "Creating Safer Communities" Program
ArcelorMittal and the American Red Cross are launching a new national partnership, Creating Safer Communities, designed to bring important safety training and res to people who live and work in communities where ArcelorMittal operates. ArcelorMittal, the world"s leading steel company, provided a grant of $152,500 to be distributed in multiple communities across the US. The program will provide health and safety education to more than 1,800 community members in addition to thousands of ArcelorMittal employees and their families.
News of the day
Provectus Pharmaceuticals Initiates New PH-10 Clinical Study For Psoriasis
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has initiated a new Phase 2 clinical trial of PH-10 for psoriasis involving daily dosing of patients for 28 days. After reviewing safety and efficacy data from its PH-10 trial for atopic dermatitis, Provectus determined that daily dosing of patients with psoriasis trial would be an appropriate and attractive regimen. The new study supplants an earlier Phase 2 study, using twice weekly dosing for 12 weeks, which was terminated earlier in June.
Nutrition

A Growing Number Of Brits Cross The Atlantic For Donor Egg IVF Treatment At Shady Grove Fertility Center

More and more couples from the United Kingdom are crossing the ocean for donor egg treatment at Shady Grove Fertility Center, the Washington/Baltimore area"s largest in vitro fertilization (IVF) and fertility clinic. More than five dozen British patients received IVF treatment there last year, which was a 350-percent increase over 2007; most were donor egg recipients. In a reversal of the medical tourism flow of Americans overseas in search of less costly elective medical procedures, many British fertility patients who need to use donor eggs rather than their own are flocking to Shady Grove Fertility Center (SGFC). In the UK, where egg donors are neither paid nor guaranteed anonymity, donor eggs are scarce, wait times can be as long as three years and choice of donor is limited. In contrast, Shady Grove Fertility not only pays donors, but also offers an innovative way to reduce waiting time and cost for donor eggs. In addition to the traditional donor egg method of matching each donor with a single recipient, Shady Grove Fertility Center patients also have the option of enrolling in what"s called "Shared Donor Egg," a unique program through which one donor"s eggs may be shared by two or three recipients. Whichever option a patient selects, pregnancy rates are comparable. The collaborative treatment process involves only two visits to SGFC per cycle of donor egg treatment. On the first visit to SGFC, the male partner"s sperm is frozen and an egg donor is selected. The couple then returns to the UK, where an SGFC partner clinic provides additional treatment and support -- such as hormone injections to prepare the woman"s uterus for pregnancy -- while SGFC harvests the donor"s eggs and fertilizes them in vitro with the thawed sperm. Only then does the couple return to Maryland for embryo transfer. This streamlined, trans-Atlantic system results in pregnancy success rates comparable to those of couples using fresh sperm. "In some countries, infertility treatments are very limited or restricted and may even be illegal," said Michael J. Levy, M.D., Shady Grove Fertility Center"s founder, who in late 2007 began establishing relationships with doctors and fertility clinics in the UK. "We at Shady Grove Fertility are proud that word has reached the other side of the Atlantic about our innovative financing programs, our strong emphasis on quality patient care, and our outstanding IVF success rates." Using the UK program as a model, SGFC has a late June trip planned to Ireland to explore setting up a similar set of relationships with potential partner clinics, as well as interested patients. About Shady Grove Fertility Center Shady Grove Fertility Center is America"s largest private fertility center, performing more than 3,500 in vitro fertilization (IVF) cycles annually -- more than all other Baltimore/Washington area fertility clinics combined. Twenty-one reproductive endocrinologists, Ph.D. scientists and geneticists, as well as 350 specialized staff care for patients in 11 full-service offices throughout the Washington, DC, and Baltimore areas. Shady Grove Fertility offers a comprehensive range of fertility treatment options including IVF, donor egg and pre-implantation genetic diagnosis (PGD) and integrative holistic care, as well as res to address all patients" needs -- medical, emotional, and financial. Shady Grove Fertility conducts clinical research in collaboration with the National Institutes of Health and is part of their subspecialty training Fellowship in Reproductive Endocrinology. Since Shady Grove Fertility"s inception in 1992, more than 15,000 IVF babies have born. Shady Grove Fertility physicians have been featured as experts for comment on media outlets such as NBC"s The Today Show, The New York Times, NPR"s Diane Rehm Show (WAMU-FM 88.5, Washington, DC), and Parent Magazine. Washingtonian magazine listed Shady Grove Fertility among the area"s Best Places to Work in 2007. Shady Grove Fertility Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):